<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Mission Neet Pg Inicet Grand Test 26   29 03 2025   2025 03 29</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Mission Neet Pg Inicet Grand Test 26   29 03 2025   2025 03 29</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                200 Questions | 800 Total Marks | 210 min Duration | ~63.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 200 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 210 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 200</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Mission Neet Pg Inicet Grand Test 26   29 03 2025   2025 03 29 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 200</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 200 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 45-year-old man with a BMI of 30 kg/m¬≤ is diagnosed with stage 1 hypertension. He is advised to lose weight as part of non-pharmacological management. How much reduction in SBP per 10 kg of weight loss can he expect?", "options": [{"label": "A", "text": "1‚Äì3 mm Hg", "correct": false}, {"label": "B", "text": "3‚Äì5 mm Hg", "correct": false}, {"label": "C", "text": "5‚Äì20 mm Hg", "correct": true}, {"label": "D", "text": "20‚Äì30 mm Hg", "correct": false}], "correct_answer": "C. 5‚Äì20 mm Hg", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_oAxQ2r0.png"], "explanation": "<p><strong>Ans. C) 5‚Äì20 mm Hg</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Weight reduction is an effective non-pharmacological strategy for managing hypertension, with an expected SBP reduction of 5‚Äì20 mm Hg per 10 kg of weight loss.</li><li>‚û§ Weight reduction is an effective non-pharmacological strategy for managing hypertension, with an expected SBP reduction of 5‚Äì20 mm Hg per 10 kg of weight loss.</li><li>‚û§ Lifestyle modification to manage hypertension:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A lumbar puncture is performed on a child with suspected meningitis, and CSF analysis reveals the following findings: Pressure: Increased Leukocytes: 10-500 Lymphocytes Protein: 100-500 mg/dL (high) Glucose: < 40 mg/dL (low) Based on the CSF findings, what is the most likely diagnosis?", "options": [{"label": "A", "text": "Viral Meningitis", "correct": false}, {"label": "B", "text": "Tubercular Meningitis", "correct": true}, {"label": "C", "text": "Bacterial Meningitis", "correct": false}, {"label": "D", "text": "Brain Abscess", "correct": false}], "correct_answer": "B. Tubercular Meningitis", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gRP21Lm.png"], "explanation": "<p><strong>Ans. B) Tubercular Meningitis</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "According to the ILAR criteria for Juvenile Idiopathic Arthritis (JIA), which of the following patients would not be classified under JIA?", "options": [{"label": "A", "text": "A 5-year-old girl with Systemic JIA presenting with fever and rash", "correct": false}, {"label": "B", "text": "A 9-year-old boy with Oligoarthritis affecting 3 joints", "correct": false}, {"label": "C", "text": "A 12-year-old girl with Psoriatic arthritis and dactylitis", "correct": false}, {"label": "D", "text": "A 16-year-old male with Acute Rheumatic Fever (ARF) presenting with polyarthritis", "correct": true}], "correct_answer": "D. A 16-year-old male with Acute Rheumatic Fever (ARF) presenting with polyarthritis", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Juvenile Idiopathic Arthritis (JIA) includes several chronic arthritis subtypes, while Acute Rheumatic Fever is an inflammatory, post-streptococcal condition that does not cause chronic joint disease.</li><li>‚û§ Juvenile Idiopathic Arthritis (JIA) includes several chronic arthritis subtypes, while Acute Rheumatic Fever is an inflammatory, post-streptococcal condition that does not cause chronic joint disease.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 34-year-old man presents with abdominal pain and vomiting for 4 hours. He has been confused and tired since the onset of symptoms. He has a history of type 1 diabetes mellitus, managed with a basal-bolus insulin regimen. Investigations: Random blood glucose : 18.4 mmol/L (Normal: 4.0‚Äì7.0) Urine dipstick: Glucose: +++ Ketones: ++ Blood: Negative Leucocytes : Negative Which is the most appropriate management?", "options": [{"label": "A", "text": "0.01 unit/kg/h IV insulin", "correct": false}, {"label": "B", "text": "0.1 unit/kg/h IV insulin", "correct": false}, {"label": "C", "text": "IV 5% dextrose", "correct": false}, {"label": "D", "text": "IV 0.9% NaCl", "correct": true}], "correct_answer": "D. IV 0.9% NaCl", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) IV 0.9% NaCl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Diabetic Ketoacidosis (DKA) Management Priorities: First-line: IV 0.9% NaCl (to correct hypovolemia) Second-line: IV insulin (0.1 unit/kg/h) (to stop ketone production) Add Potassium: If serum K+ <5.5 mmol/L before insulin Add Dextrose: When glucose <14 mmol/L to prevent hypoglycemia Complication Monitoring: Watch for cerebral edema , hypokalemia , and hypoglycemia .</li><li>‚û§ Diabetic Ketoacidosis (DKA) Management Priorities: First-line: IV 0.9% NaCl (to correct hypovolemia) Second-line: IV insulin (0.1 unit/kg/h) (to stop ketone production) Add Potassium: If serum K+ <5.5 mmol/L before insulin Add Dextrose: When glucose <14 mmol/L to prevent hypoglycemia</li><li>‚û§ Diabetic Ketoacidosis (DKA) Management Priorities:</li><li>‚û§ First-line: IV 0.9% NaCl (to correct hypovolemia) Second-line: IV insulin (0.1 unit/kg/h) (to stop ketone production) Add Potassium: If serum K+ <5.5 mmol/L before insulin Add Dextrose: When glucose <14 mmol/L to prevent hypoglycemia</li><li>‚û§ First-line: IV 0.9% NaCl (to correct hypovolemia)</li><li>‚û§ First-line:</li><li>‚û§ IV 0.9% NaCl</li><li>‚û§ Second-line: IV insulin (0.1 unit/kg/h) (to stop ketone production)</li><li>‚û§ Second-line:</li><li>‚û§ IV insulin (0.1 unit/kg/h)</li><li>‚û§ Add Potassium: If serum K+ <5.5 mmol/L before insulin</li><li>‚û§ Add Potassium:</li><li>‚û§ serum K+ <5.5 mmol/L</li><li>‚û§ Add Dextrose: When glucose <14 mmol/L to prevent hypoglycemia</li><li>‚û§ Add Dextrose:</li><li>‚û§ glucose <14 mmol/L</li><li>‚û§ hypoglycemia</li><li>‚û§ Complication Monitoring: Watch for cerebral edema , hypokalemia , and hypoglycemia .</li><li>‚û§ Complication Monitoring:</li><li>‚û§ cerebral edema</li><li>‚û§ hypokalemia</li><li>‚û§ hypoglycemia</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Consider the following statements about the treatment of nicotine use disorder: Statement 1: Nicotine replacement therapy (NRT) should always be used alone and never in combination with other pharmacologic treatments. Statement 2: Varenicline acts as a partial agonist at the nicotinic acetylcholine receptor, reducing cravings and withdrawal symptoms. Statement 3: Bupropion is contraindicated in patients with a history of seizures or eating disorders. Statement 4: Behavioral therapy is a first-line treatment for nicotine dependence and enhances long-term abstinence rates. Which of the following is correct?", "options": [{"label": "A", "text": "1, 2 and 3 are correct", "correct": false}, {"label": "B", "text": "1 and 2 are correct", "correct": false}, {"label": "C", "text": "2, 3 and 4 are correct", "correct": true}, {"label": "D", "text": "All are correct", "correct": false}], "correct_answer": "C. 2, 3 and 4 are correct", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) 2, 3 and 4 are correct</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ First-line treatments for nicotine use disorder include NRT, varenicline, and bupropion, often combined with behavioral therapy for maximum efficacy. Bupropion is contraindicated in seizure-prone individuals , and combination NRT (patch + short-acting form) is more effective than monotherapy .</li><li>‚û§ First-line treatments for nicotine use disorder include NRT, varenicline, and bupropion, often combined with behavioral therapy for maximum efficacy. Bupropion is contraindicated in seizure-prone individuals , and combination NRT (patch + short-acting form) is more effective than monotherapy .</li><li>‚û§ First-line treatments for nicotine use disorder</li><li>‚û§ NRT, varenicline, and bupropion, often combined with behavioral therapy</li><li>‚û§ Bupropion is contraindicated in seizure-prone individuals</li><li>‚û§ combination NRT (patch + short-acting form) is more effective than monotherapy</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30-year-old woman with Peutz-Jeghers syndrome is undergoing routine cancer screening. She has no significant gynecologic history but is at increased risk for which of the following malignancies?", "options": [{"label": "A", "text": "Endometrial carcinoma", "correct": false}, {"label": "B", "text": "Granulosa cell tumor of the ovary", "correct": true}, {"label": "C", "text": "Serous ovarian carcinoma", "correct": false}, {"label": "D", "text": "Invasive lobular carcinoma of the breast", "correct": false}], "correct_answer": "B. Granulosa cell tumor of the ovary", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Granulosa cell tumor of the ovary</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Peutz-Jeghers syndrome increases the risk of sex cord-stromal tumors (e.g., granulosa cell tumors) due to STK11 mutations.</li><li>‚û§ Peutz-Jeghers syndrome increases the risk of sex cord-stromal tumors (e.g., granulosa cell tumors) due to STK11 mutations.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Identify the type of plexus marked in the picture with a blue arrow:", "options": [{"label": "A", "text": "Arterial", "correct": false}, {"label": "B", "text": "Venous", "correct": true}, {"label": "C", "text": "Both A & B", "correct": false}, {"label": "D", "text": "AV Malformation", "correct": false}], "correct_answer": "B. Venous", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-22%20101205.jpg"], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qDhUuoi.jpeg"], "explanation": "<p><strong>Ans. B) Venous</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Woodruff‚Äôs plexus is primarily a venous plexus (Option B) located in the posterior part of the nasal cavity . It is known for being a potential site of significant posterior nosebleeds , particularly in adults . Understanding its venous nature is important in the clinical management of posterior epistaxis.</li><li>‚û§ Woodruff‚Äôs plexus is primarily a venous plexus (Option B) located in the posterior part of the nasal cavity .</li><li>‚û§ venous plexus</li><li>‚û§ posterior part</li><li>‚û§ nasal cavity</li><li>‚û§ It is known for being a potential site of significant posterior nosebleeds , particularly in adults .</li><li>‚û§ potential site</li><li>‚û§ significant posterior nosebleeds</li><li>‚û§ adults</li><li>‚û§ Understanding its venous nature is important in the clinical management of posterior epistaxis.</li><li>‚û§ venous nature</li><li>‚û§ clinical management</li><li>‚û§ posterior epistaxis.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 51-year-old man presents with difficulty speaking fluently for 3 hours, but his comprehension is intact. He also has left-sided weakness and homonymous hemianopia. Investigations: CT Angiography : What is the most appropriate next step in management?", "options": [{"label": "A", "text": "Carotid artery endarterectomy", "correct": false}, {"label": "B", "text": "Clopidogrel", "correct": false}, {"label": "C", "text": "IV thrombolysis", "correct": false}, {"label": "D", "text": "IV thrombolysis and thrombectomy", "correct": true}], "correct_answer": "D. IV thrombolysis and thrombectomy", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rOPy6lh.png"], "explanation_images": [], "explanation": "<p><strong>Ans. D) IV thrombolysis and thrombectomy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Acute ischemic stroke due to a large vessel occlusion in the anterior circulation (MCA) requires IV thrombolysis (if within 4.5 hours) and mechanical thrombectomy (if within 6 hours) for best functional recovery.</li><li>‚û§ Acute ischemic stroke due to a large vessel occlusion in the anterior circulation (MCA) requires IV thrombolysis (if within 4.5 hours) and mechanical thrombectomy (if within 6 hours) for best functional recovery.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 64-year-old man presents with diffuse erythroderma, pruritus, and thickened skin over several months. Physical examination reveals generalized lymphadenopathy and lichenified plaques on his torso and extremities. Peripheral blood smear shows circulating atypical lymphocytes with cerebriform nuclei. Which of the following laboratory findings is most characteristic of this condition?", "options": [{"label": "A", "text": "CD5 and Cyclin D1 positivity", "correct": false}, {"label": "B", "text": "CD4:CD8 ratio >10 and loss of CD7 expression", "correct": true}, {"label": "C", "text": "Presence of Bence-Jones proteins in urine", "correct": false}, {"label": "D", "text": "Decreased CD19+ B-cell population in peripheral blood", "correct": false}], "correct_answer": "B. CD4:CD8 ratio >10 and loss of CD7 expression", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) CD4:CD8 ratio >10 and loss of CD7 expression</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective</li><li>‚û§ S√©zary Syndrome is a leukemic variant of cutaneous T-cell lymphoma with a high CD4:CD8 ratio, loss of CD7, and circulating S√©zary cells with cerebriform nuclei.</li><li>‚û§ S√©zary Syndrome is a leukemic variant of cutaneous T-cell lymphoma with a high CD4:CD8 ratio, loss of CD7, and circulating S√©zary cells with cerebriform nuclei.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 34-year-old woman with a history of postpartum hemorrhage undergoes thromboelastography (TEG) analysis for abnormal bleeding. The results show: R time: Prolonged K time: Normal Œ±-angle: Normal MA: Normal Which of the following is the most likely explanation for these findings?", "options": [{"label": "A", "text": "Deficiency of fibrinogen", "correct": false}, {"label": "B", "text": "Factor VIII deficiency", "correct": true}, {"label": "C", "text": "Platelet dysfunction", "correct": false}, {"label": "D", "text": "Hyper-fibrinolysis", "correct": false}], "correct_answer": "B. Factor VIII deficiency", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-21%20111233.jpg"], "explanation": "<p><strong>Ans. B) Factor VIII deficiency</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ A prolonged R time with normal fibrinogen and platelet function suggests a coagulation factor deficiency, such as hemophilia A.</li><li>‚û§ A prolonged R time with normal fibrinogen and platelet function suggests a coagulation factor deficiency, such as hemophilia A.</li><li>‚û§ TEG Interpretation & Treatment</li><li>‚û§ TEG Interpretation & Treatment</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A researcher studying caloric restriction and longevity finds that nutrient deprivation increases autophagy in cultured cells. This effect is abolished when cells are treated with an inhibitor targeting a key regulatory pathway. Which of the following pathways is most likely involved in autophagy suppression in nutrient-rich conditions?", "options": [{"label": "A", "text": "mTOR activation", "correct": true}, {"label": "B", "text": "AMPK activation", "correct": false}, {"label": "C", "text": "p53 tumor suppressor pathway", "correct": false}, {"label": "D", "text": "Wnt/Œ≤-catenin signalling", "correct": false}], "correct_answer": "A. mTOR activation", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) mTOR activation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective</li><li>‚û§ mTOR is a key negative regulator of autophagy and is inhibited by caloric restriction, promoting cell survival and longevity.</li><li>‚û§ mTOR is a key negative regulator of autophagy and is inhibited by caloric restriction, promoting cell survival and longevity.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 67-year-old woman presents with reduced exercise tolerance and shortness of breath while lying down (orthopnea). She had an ST-elevated myocardial infarction (STEMI) three years ago . Examination reveals a raised JVP and a displaced apex beat. Investigations: Echocardiogram: Ejection fraction (EF) = 0.38 (38%) Which is the most appropriate management?", "options": [{"label": "A", "text": "Amlodipine", "correct": false}, {"label": "B", "text": "Bisoprolol", "correct": false}, {"label": "C", "text": "Furosemide", "correct": true}, {"label": "D", "text": "Losartan", "correct": false}], "correct_answer": "C. Furosemide", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Npj6Eoe.png"], "explanation": "<p><strong>Ans. C) Furosemide</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Furosemide is the most appropriate first-line treatment for symptomatic relief of pulmonary congestion in acute decompensated heart failure.</li><li>‚û§ Furosemide is the most appropriate first-line treatment for symptomatic relief of pulmonary congestion in acute decompensated heart failure.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following statements regarding the utility of eFAST in trauma patients are correct? eFAST is performed during the primary survey of trauma patients. eFAST can reliably exclude injuries in penetrating trauma. eFAST is unreliable in detecting small amounts of free blood (<80 mL). eFAST is not useful for assessing retroperitoneal injuries.", "options": [{"label": "A", "text": "1, 2, 3", "correct": false}, {"label": "B", "text": "1, 3, 4", "correct": true}, {"label": "C", "text": "2, 3, 4", "correct": false}, {"label": "D", "text": "1 and 4", "correct": false}], "correct_answer": "B. 1, 3, 4", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) 1, 3, 4</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ eFAST is a valuable rapid imaging tool in trauma , especially in unstable patients, but it cannot reliably exclude injuries in penetrating trauma, misses small fluid collections , and is unreliable for retroperitoneal assessment .</li><li>‚û§ eFAST is a valuable rapid imaging tool in trauma , especially in unstable patients, but it cannot reliably exclude injuries in penetrating trauma, misses small fluid collections , and is unreliable for retroperitoneal assessment .</li><li>‚û§ eFAST is a</li><li>‚û§ , especially in unstable patients, but it</li><li>‚û§ injuries in penetrating trauma,</li><li>‚û§ , and is</li><li>‚û§ .</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 42-year-old male undergoing immunosuppressive therapy with cyclosporine after a kidney transplant presents to the clinic for a routine follow-up. Which of the following are recognized complications associated with cyclosporine therapy in this patient? 1. Hypertension 2. Pulmonary fibrosis 3. Hirsutism 4. Nephrotoxicity 5. Hyperkalemia", "options": [{"label": "A", "text": "1, 2 and 5", "correct": false}, {"label": "B", "text": "2, 3 and 4", "correct": false}, {"label": "C", "text": "1, 3, 4 and 5", "correct": true}, {"label": "D", "text": "1, 2, 3 and 4", "correct": false}], "correct_answer": "C. 1, 3, 4 and 5", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) 1, 3, 4 and 5</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective</li><li>‚û§ The common complications associated with cyclosporine therapy, particularly in post-transplant patients, including hypertension, hirsutism, nephrotoxicity, and hyperkalemia, to monitor and manage these side effects effectively in clinical practice.</li><li>‚û§ The common complications associated with cyclosporine therapy, particularly in post-transplant patients, including hypertension, hirsutism, nephrotoxicity, and hyperkalemia, to monitor and manage these side effects effectively in clinical practice.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 50-year-old woman presents with progressive dysphagia to solids, unintentional weight loss, and early satiety. Upper endoscopy reveals thickened gastric folds with linitis plastica. A biopsy shows signet ring cells infiltrating the gastric wall. Which of the following additional malignancies is most strongly associated with the genetic mutation underlying this patient‚Äôs disease?", "options": [{"label": "A", "text": "Medullary thyroid carcinoma", "correct": false}, {"label": "B", "text": "Lobular breast carcinoma", "correct": true}, {"label": "C", "text": "Pheochromocytoma", "correct": false}, {"label": "D", "text": "Renal cell carcinoma", "correct": false}], "correct_answer": "B. Lobular breast carcinoma", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Lobular breast carcinoma</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective</li><li>‚û§ CDH1 mutations cause hereditary diffuse gastric cancer and lobular breast carcinoma due to loss of cell adhesion.</li><li>‚û§ CDH1 mutations cause hereditary diffuse gastric cancer and lobular breast carcinoma due to loss of cell adhesion.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 61-year-old man presents with: Fatigue, night sweats, and weakness for the past 5 months Type 2 diabetes mellitus, managed with metformin Mild conjunctival pallor with splenomegaly and petechiae Investigations: Haemoglobin: 111 g/L (Normal range: 130‚Äì180) Platelets: 524 √ó 10‚Åπ/L (Normal range: 150‚Äì400) Cytogenetic analysis: What is the most likely diagnosis?", "options": [{"label": "A", "text": "Acute myeloid leukaemia", "correct": false}, {"label": "B", "text": "Chronic myeloid leukaemia", "correct": true}, {"label": "C", "text": "Hodgkin lymphoma", "correct": false}, {"label": "D", "text": "Multiple myeloma", "correct": false}], "correct_answer": "B. Chronic myeloid leukaemia", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_y52WWSg.png"], "explanation_images": [], "explanation": "<p><strong>Ans. B) Chronic myeloid leukaemia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Chronic myeloid leukaemia (CML) is a hematologic malignancy characterized by the Philadelphia chromosome (t(9;22)) and BCR-ABL1 fusion gene , leading to uncontrolled cell proliferation . Symptoms of CML include fatigue , night sweats , splenomegaly , petechiae , anaemia , and thrombocytosis . Diagnosis is confirmed by cytogenetic analysis showing the Philadelphia chromosome . Treatment for CML includes targeted therapy with tyrosine kinase inhibitors (e.g., imatinib ), which effectively blocks the abnormal protein produced by the BCR-ABL1 fusion gene .</li><li>‚û§ Chronic myeloid leukaemia (CML) is a hematologic malignancy characterized by the Philadelphia chromosome (t(9;22)) and BCR-ABL1 fusion gene , leading to uncontrolled cell proliferation .</li><li>‚û§ Chronic myeloid leukaemia (CML)</li><li>‚û§ hematologic malignancy</li><li>‚û§ Philadelphia chromosome</li><li>‚û§ BCR-ABL1 fusion gene</li><li>‚û§ uncontrolled cell proliferation</li><li>‚û§ Symptoms of CML include fatigue , night sweats , splenomegaly , petechiae , anaemia , and thrombocytosis .</li><li>‚û§ CML</li><li>‚û§ fatigue</li><li>‚û§ night sweats</li><li>‚û§ splenomegaly</li><li>‚û§ petechiae</li><li>‚û§ anaemia</li><li>‚û§ thrombocytosis</li><li>‚û§ Diagnosis is confirmed by cytogenetic analysis showing the Philadelphia chromosome .</li><li>‚û§ Diagnosis</li><li>‚û§ cytogenetic analysis</li><li>‚û§ Philadelphia chromosome</li><li>‚û§ Treatment for CML includes targeted therapy with tyrosine kinase inhibitors (e.g., imatinib ), which effectively blocks the abnormal protein produced by the BCR-ABL1 fusion gene .</li><li>‚û§ Treatment</li><li>‚û§ CML</li><li>‚û§ targeted therapy</li><li>‚û§ tyrosine kinase inhibitors</li><li>‚û§ imatinib</li><li>‚û§ BCR-ABL1 fusion gene</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient presents with a left breast lump of size 3cm x 4cm. The overlying skin has a ‚Äòorange-like skin‚Äô appearance. On the right side, mobile axillary nodes are palpable. On the left side, supraclavicular lymph nodes are palpable. The most appropriate tumor staging is:", "options": [{"label": "A", "text": "T2 N2a M0", "correct": false}, {"label": "B", "text": "T4b N3c M0", "correct": false}, {"label": "C", "text": "T2 N3c M1", "correct": false}, {"label": "D", "text": "T4b N3c M1", "correct": true}], "correct_answer": "D. T4b N3c M1", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) T4b N3c M1</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ For breast cancer presenting with a Peau d